Old Web
English
Sign In
Acemap
>
authorDetail
>
SoliMix Trial investigators
SoliMix Trial investigators
Medicine
Basal insulin
baseline characteristics
Internal medicine
Type 2 diabetes
2
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Author response for "Advancing therapy with iGlarLixi versus Premix 70/30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomised controlled trial"
2021
Diabetes, Obesity and Metabolism
Rory J. McCrimmon
Saud Al Sifri
Rifat Emral
Viswanathan Mohan
Leobardo Sauque-Reyna
Carlos Trescoli
Nebojsa Lalic
Agustina Álvarez
Nacima Demil
Mathieu Coudert
Alka Shaunik
Mireille Bonnemaire
Julio Rosenstock
SoliMix Trial investigators
Show All
Source
Cite
Save
Citations (0)
Advancing therapy with iGlarLixi versus Premix 70/30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomised controlled trial
2021
Diabetes, Obesity and Metabolism
Rory J. McCrimmon
Saud Al Sifri
Rifat Emral
Viswanathan Mohan
Leobardo Sauque-Reyna
Carlos Trescoli
Nebojsa Lalic
Agustina Álvarez
Nacima Demil
Mathieu Coudert
Alka Shaunik
Mireille Bonnemaire
Julio Rosenstock
SoliMix Trial investigators
Show All
Source
Cite
Save
Citations (4)
1